v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities:    
Net income $ 515,742 $ 531,787
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss from disposal of assets, impairments and other 7,164 11,480
Adjustment to closure and post-closure liabilities 131,980 0
Depreciation 545,762 499,728
Amortization of intangibles 94,864 97,878
Deferred income taxes, net of acquisitions 37,189 58,292
Current period provision for expected credit losses 14,519 5,171
Amortization of debt issuance costs 4,502 4,101
Share-based compensation 41,539 41,956
Interest accretion 22,156 25,556
Payment of contingent consideration recorded in earnings (1) (400)
Adjustments to contingent consideration (1,315) 30,584
Other (3,778) (2,661)
Changes in operating assets and liabilities, net of effects from acquisitions:    
Net change in operating assets and liabilities, net of acquisitions (131,437) (123,731)
Net cash provided by operating activities 1,278,886 1,179,741
Cash Flows from Investing Activities:    
Payments for acquisitions, net of cash acquired (309,644) (510,738)
Capital expenditures for property and equipment (598,949) (497,765)
Capital expenditures for undeveloped land (51,049) 0
Proceeds from disposal of assets 2,922 5,417
Other (5,232) (16,886)
Net cash used in investing activities (961,952) (1,019,972)
Cash Flows from Financing Activities:    
Proceeds from long-term debt 1,703,552 1,613,594
Principal payments on notes payable and long-term debt (1,176,382) (1,488,785)
Payment of contingent consideration recorded at acquisition date (4,707) (22,895)
Change in book overdraft 14,244 397
Payments for repurchase of common shares (614,507) (389)
Payments for cash dividends (177,101) (162,950)
Tax withholdings related to net share settlements of equity-based compensation (24,985) (30,934)
Debt issuance costs (5,676) (3,433)
Proceeds from issuance of shares under employee share purchase plan 3,031 2,593
Proceeds from sale of common shares held in trust 0 324
Net cash provided by (used in) financing activities (282,531) (92,478)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,405) 2,007
Net increase in cash, cash equivalents and restricted cash 31,998 69,298
Cash, cash equivalents and restricted cash at beginning of year 229,580 198,173
Cash, cash equivalents and restricted cash at end of year 261,578 267,471
Non-cash investing and financing activities:    
Liabilities assumed and notes payable issued to sellers of businesses acquired 29,940 117,481
Accrued capital expenditures for property and equipment $ 65,916 $ 50,161